Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
UC Irvine Alpha Clinic, Irvine, California Azul Vision - California Eye Specialists Medical Group Inc., Pasadena, California Midwest Cornea Associates, Carmel, Indiana Vance Thompson Vision, Alexandria, Minnesota Minnesota Eye Consultants, Minnetonka, Minnesota St. Louis Eye Institute, Town and Country, Missouri Metropolitan Eye Research and Surgery Institute, Palisades Park, New Jersey Vance Thompson Vision, West Fargo, North Dakota UPMC Vision Institute, Pittsburgh, Pennsylvania